Coloplast revenue and financials
kr 419.70Change from previous close: +0.21%Absolute change: +kr 0.90
In the fiscal year ended September 2024, Coloplast reported revenue of kr 27.03B (+10.33% year over year). Net income was kr 5.05B, a net margin of 18.7%.
Fiscal year ending in September. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +10.33%
- FY to Sep 2024 vs FY to Sep 2023
- Net income growth
- +5.62%
- FY to Sep 2024 vs FY to Sep 2023
- Net margin
- 18.7%
- FY to Sep 2023: 19.5%
Financial data
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 1,710 | 1,466 | 2,233 | 1,631 | 742 |
| Depreciation and amortization | 363 | 3,349 | 345 | 343 | 344 |
| Capital expenditure | -296 | -449 | -414 | -418 | -310 |
| Investing cash flow | -292 | -612 | -412 | -419 | -309 |
| Financing cash flow | -1,680 | -934 | -1,642 | -1,184 | -598 |
| Dividends paid | -1,126 | 0.0 | -4,057 | -1,127 | 0.0 |
| Debt issued | -834 | -507 | 2,484 | 12.0 | -521 |
| Effect of exchange rates | — | 19.0 | -1.0 | — | -12.0 |
| Net change in cash | -262 | -80.0 | 179 | 28.0 | -165 |
| Free cash flow | 1,414 | 1,017 | 1,819 | 1,213 | 432 |